We are live on
!
Find out more
CCP
Cryder Capital Partners Portfolio holdings
AUM
$1.53B
1-Year Est. Return
9.36%
This Fund
S&P 500
This Quarter
Est. Return
+11.36%
1 Year Est. Return
+9.36%
3 Year Est. Return
+71.2%
5 Year Est. Return
+84.02%
10 Year Est. Return
+425.03%
AUM
$247M
AUM Growth
+$22.7M
(+10%)
Cap. Flow
-$921K
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
94.96%
Holding
11
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$164K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.73% |
| 2 | Communication Services | 25.82% |
| 3 | Financials | 25.69% |
| 4 | Technology | 11.77% |
Similar funds
HR
SG
FBB
FI
MCP
CCM
AF
ICM
Cryder Capital Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Cryder Capital Partners held 11 positions worth $247M, up 10% from $224M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Trading was light in Q1 2017: portfolio turnover was 0%. Cryder Capital Partners opened no new positions and made no exits, leaving the 11-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 37% a quarter earlier, followed by Communication Services and Financials.
- Cryder Capital Partners added most to Thermo Fisher Scientific in Q1 2017, an estimated $164K increase.
- Cryder Capital Partners's biggest Q1 2017 reduction was HCA Healthcare, cutting an estimated $1.09M.
- Cryder Capital Partners's ten largest holdings make up 95% of its $247M portfolio in Q1 2017.
- Cryder Capital Partners opened 0 new positions and closed 0 in Q1 2017.
- Cryder Capital Partners's portfolio value rose 10% quarter-over-quarter to $247M.
Based on Cryder Capital Partners's 13F filing for Q1 2017, filed 26 Apr 2017.